Surviving Sepsis Campaign 2026 Guidelines Overhaul Adult Sepsis Management

The SCCM/ESICM 2026 update adds prehospital and MDR-stratified antimicrobial guidance, elevates prolonged beta-lactam infusion to a strong recommendation, and expands biomarker, hemodynamic, and long-term recovery statements directly relevant to ICU pharmacists.

Surviving Sepsis Campaign 2026SCCMESICMsepsisseptic shockbeta-lactamsvasopressorscorticosteroidsantimicrobial stewardshipcritical care Critical Care / ICU

Background Information

2026 sepsis guidelines enhance antimicrobial and fluid strategies.

The 2026 guidelines provide crucial updates for managing sepsis and septic shock, impacting treatment strategies in critical care settings. There are 129 recommendation statements, 46 of which are new, addressing antimicrobial initiation timing, fluid resuscitation, and antimicrobial stewardship. Updates include prehospital antimicrobial administration for long transport times, avoiding empiric anti-anaerobic coverage in low-risk patients, and restricting antifungal use, which streamline critical care workflows. The 2026 guidelines refine antimicrobial and fluid strategies for sepsis management.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Prescott HC, Antonelli M, Alhazzani W, Møller MH, Alshamsi F, Azevedo LCP, Belley-Cote E, De Waele J, Derde L, Dionne JC, Evans L, Gershengorn HB, Hodgson CL, Honarmand K, Kesecioglu J, McIntyre L, Mer M, Nunnally ME, Oczkowski SJW, Rochwerg B, Akinola OO, Akuamoah-Boateng KA, Alberto L, Angus DC, Arabi YM, Azoulay E, Cecconi M, Convocar PF, De Pascale G, Doi K, Du B, Egi M, Elie-Turenne MC, Ferrer R, Fox-Robichaud A, French C, Freund Y, Gong MN, Hale CP, Hammond NE, Hashmi M, Heunks L, Iwashyna TJ, Jacob ST, Klompas M, Kwizera A, Leeies M, Lejnieks JD, Levy MM, Machado FR, Maia MO, Masur H, Maves RC, McGloughlin S, McPeake J, Mohr NM, Myatra SN, Ostermann M, Peake SL, Pletz MW, Roberts JA, Rosa RG, Sawyer RG, Schorr CA, Simpson SQ, Weng L, Wiersinga WJ, Rhodes A, Coopersmith CM

Citation: Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Critical care medicine. 2026;54(4):725-812. doi:10.1097/CCM.0000000000007075

Article Links: PubMed · Journal / DOI

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →